Version 1
: Received: 17 March 2021 / Approved: 18 March 2021 / Online: 18 March 2021 (10:59:34 CET)
How to cite:
Camacho, C.; Leon-Rojas, J.E. Platelet-Rich Fibrin Membrane for Pterygium Surgery: A Case Report, Literature Review and Feasibility Assessment. Preprints2021, 2021030473. https://doi.org/10.20944/preprints202103.0473.v1
Camacho, C.; Leon-Rojas, J.E. Platelet-Rich Fibrin Membrane for Pterygium Surgery: A Case Report, Literature Review and Feasibility Assessment. Preprints 2021, 2021030473. https://doi.org/10.20944/preprints202103.0473.v1
Camacho, C.; Leon-Rojas, J.E. Platelet-Rich Fibrin Membrane for Pterygium Surgery: A Case Report, Literature Review and Feasibility Assessment. Preprints2021, 2021030473. https://doi.org/10.20944/preprints202103.0473.v1
APA Style
Camacho, C., & Leon-Rojas, J.E. (2021). Platelet-Rich Fibrin Membrane for Pterygium Surgery: A Case Report, Literature Review and Feasibility Assessment. Preprints. https://doi.org/10.20944/preprints202103.0473.v1
Chicago/Turabian Style
Camacho, C. and Jose Eduardo Leon-Rojas. 2021 "Platelet-Rich Fibrin Membrane for Pterygium Surgery: A Case Report, Literature Review and Feasibility Assessment" Preprints. https://doi.org/10.20944/preprints202103.0473.v1
Abstract
Pterygium is a common ocular disease caused by abnormal cellular proliferation leading to abnormal fibrovascular growth of the conjunctiva. The main treatment is surgical removal; however, despite the improvement of surgical techniques and development of adjuvant therapies, postoperative recurrence, which can be as high as 89%, remains a challenge. Currently, pterygium excision with conjunctival autograft remains the preferred surgical technique to decrease recurrence, especially when combined with ciclosporin eye drops. Nevertheless, there is no gold standard surgical technique to prevent pterygium recurrence. Therefore, this review aims to assess the safety, effectiveness and, applicability of platelet-rich fibrin membrane for primary pterygium surgery and assess its possible benefits in resource-limited settings.
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
